Treatment of moderate-to-severe psoriasis in clinical practice: A survey of spanish dermatologists;Realidad teraputica de la psoriasis moderada-grave en Espaa. Encuesta de opinin

Actas Dermo-Sifiliograficas

Volumn 101, Issue 10, 2010, Pages 858-865

  Moreno Ramirez D ^a   Fonseca, E ^b   Herranz, P ^c   Ara, M ^d  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Dermatology; Disease management; Psoriasis; Spain; Survey

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; SPAIN; ADULT; CROSS-SECTIONAL STUDY; DERMATOLOGY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED;

ADULT; CROSS-SECTIONAL STUDIES; DERMATOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSORIASIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 85047687785     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(10)70733-2     Document Type: Article

References (24)

1. C. Ferrndiz, X. Bordas, V. García-Patos, S. Puig, R. Pujol, and A. Smandia Prevalence of psoriasis in Spain (Epiderma Project: phase I) J Eur Acad Dermatol 15 2001 20 23
2. Lodeiro C, Pea J, del Pozo J. Psoriasis. Guías Clnicas. Fisterra 2003. Disponible en: http://www.fisterra.com/guias2/psoriasis.asp.
3. L. Puig, X. Bordas, J.M. Carrascosa, E. Daudn, C. Ferrndiz, and J.M. Herranz Documento de consenso sobre la evaluacin y el tratamiento de la psoriasis moderada/grave del grupo Espaol de Psoriasis de la Academia Española de Dermatología y Venereología Actas Dermosifiliogr 100 2009 277 286
4. F. Sampogna, F. Sera, and D. Abeni Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: A cluster analysis J Invest Dermatol 122 2004 602 607
5. T. Fredriksson, and U. Pettersson Severe psoriasis-oral therapy with a new retinoid Dermatologica 157 1978 238 244
6. Gabinete de Estudios Sociolgicos Bernard Krief La problemtica de la psoriasis en Espaa y su futuro. Estudio prospectivo Delphi Psoriasis 2000 2000 Bernard Krief Madrid
7. K. Reich, and U. Mrowietz Treatment goals in psoriasis JDDG 5 2007 566 574
8. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriatic artritis. J Am Acad Dermatol 2009 (in press)
9. J.P. Callen, G.G. Krueger, M. Lebwohl, E.I. McBurney, P. Mease, and A. Menter AAD consensus statement on psoriasis therapies J Am Acad Dermatol 49 2003 897 899
10. S.R. Feldman, J.Y. Koo, A. Menter, and J. Bagel Decision points for the initiation of systemic treatment for psoriasis J Am Acad Dermatol 53 2005 101 107
11. M. Lebwohl A clinician's paradigm in the treatment of psoriasis J Am Acad Dermatol 53 1 Suppl 1 2005 S59 S69
12. R. Gamo, and J.L. López-Estebaranz Terapia biolgica y psoriasis Actas Dermosifiliogr 97 2006 1 17
13. A.Y. Finlay, and J.P. Ortonne Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy J Cutan Med Surg 8 2004 310 320
14. K. Reich, R. Sinclair, G. Roberts, C.E.M. Griffiths, M. Tabberer, and J. Barker Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a metanalysis Curr Med Res Opin 24 2008 1237 1254
15. G. Krueger, R.G. Langley, A.Y. Finlay, C.E. Griffiths, J.M. Woolley, and D. Lalla Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase iii trial Br J Dermatol 153 2005 1192 1199
16. Unmet Needs in the Management of Plaque Psoriasis. Clinical Briefs 2009;18(1). [consultado 28/7/2009]. Disponible en: http://www.managedcaremag. com/supplements/0901-CB-Plaque-Psoriasis/CB-Plaque-Psoriasis-MC.pdf.
17. L. Dubertret, U. Mrowietz, A. Ranki, P.C.M. van de Kerhof, S. Chimenti, and T. Lotti European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey Br J Dermatol 155 2006 729 736
18. J. Garduno, M.J. Bhosle, R. Balkrishnan, and S.R. Feldman Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review J Dermatolog Treat 18 2007 223 242
19. C. Ferrndiz Foraster, A. García-Dez, L. Lizn Tudela, L. Bermdez-Rey, and X. Bada Llach Impacto de la psoriasis en la Calidad de Vida relacionada con la salud Med Clin (Barc) 128 2007 325 329
20. M. Ribera, A. Mirada, C. Spa, X. Soria, and C. Ferrandiz Encuesta sobre la psoriasis realizada a dermatlogos espaoles Piel 20 2005 107 111
21. M.J. Bhosle, A. Kulkarni, S.R. Feldman, and R. Balkrishnan Quality of life in patients with psoriasis Health Qual Life Outcomes 4 2006 35
22. V.K. Sharma, B. Dutta, and M. Ramam Hydroxyurea as an alternative therapy for psoriasis Indian J Dermatol Venereol Leprol 70 2004 13 17
23. M. Lebwohl, P.T. Ting, and J.Y.M. Koo Psoriasis treatment: traditional therapy Ann Rheum Dis 64 2005 ii83 ii86
24. V. Zaragoza, A. Pérez, J.L. Sánchez, V. Oliver, L. Martnez, and V. Alegre Seguridad y eficacia de etanercept a largo plazo en el tratamiento de la psoriasis Actas Dermosifiliogr 101 2010 47 53